We are live on ! Find out more
VFA

Virtus Fund Advisers Portfolio holdings

AUM $32.1M
1-Year Est. Return 39.5%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+39.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.1M
AUM Growth
-$40.2K
Cap. Flow
+$52.1K
Cap. Flow %
0.37%
Top 10 Hldgs %
68.53%
Holding
119
New
18
Increased
17
Reduced
9
Closed
19

Top Buys

Rank Stock Value
1
VIPS icon
Vipshop
VIPS
+$444K
2
JBI icon
Janus International
JBI
+$85K
3
NMIH icon
NMI Holdings
NMIH
+$56K
4
KBH icon
KB Home
KBH
+$53.4K
5
ANIP icon
ANI Pharmaceuticals
ANIP
+$50.2K

Sector Composition

Rank Sector Weight
1 Financials 19.41%
2 Materials 16.32%
3 Consumer Discretionary 14.03%
4 Energy 11.99%
5 Technology 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THC icon
76
Tenet Healthcare
THC
$22.2B
$29K 0.21%
440
-512
-54% -$38.3K
HALO icon
77
Halozyme
HALO
$9.85B
$28.6K 0.2%
750
P
78
Everpure Inc
P
$23.5B
$27.7K 0.2%
+777
New +$28.8K
FUL icon
79
H.B. Fuller
FUL
$2.99B
$27.6K 0.2%
403
-175
-30% -$12.4K
QTWO icon
80
Q2 Holdings
QTWO
$3.84B
$27K 0.19%
+837
New +$27.7K
BLKB icon
81
Blackbaud
BLKB
$1.99B
$26.6K 0.19%
+378
New +$27.8K
TK icon
82
Teekay
TK
$995M
$26.2K 0.19%
+4,242
New +$27.1K
TAC icon
83
TransAlta
TAC
$3.94B
$26.1K 0.18%
2,997
+588
+24% +$5.71K
PEGA icon
84
Pegasystems
PEGA
$5.01B
$26K 0.18%
1,200
OSW icon
85
OneSpaWorld
OSW
$2.64B
$26K 0.18%
+2,319
New +$27K
BPMC
86
DELISTED
Blueprint Medicines
BPMC
$26K 0.18%
518
MBC icon
87
MasterBrand
MBC
$1.08B
$26K 0.18%
+2,141
New +$26.3K
VCEL icon
88
Vericel Corp
VCEL
$2.36B
$25.7K 0.18%
766
AXNX
89
DELISTED
Axonics, Inc. Common Stock
AXNX
$25.3K 0.18%
451
AYX
90
DELISTED
Alteryx Inc
AYX
$23.9K 0.17%
+634
New +$22.7K
CYTK icon
91
Cytokinetics
CYTK
$10.7B
$23.2K 0.16%
789
+239
+43% +$7.96K
EVBG
92
DELISTED
Everbridge, Inc. Common Stock
EVBG
$23.1K 0.16%
1,031
+178
+21% +$4.59K
WNC icon
93
Wabash National
WNC
$535M
$23K 0.16%
1,091
INSP icon
94
Inspire Medical Systems
INSP
$1.48B
$22.8K 0.16%
115
SUPN icon
95
Supernus Pharmaceuticals
SUPN
$2.71B
$19.7K 0.14%
714
AGEN
96
Agenus
AGEN
$282M
$19.6K 0.14%
+867
New +$24.6K
STRO icon
97
Sutro Biopharma
STRO
$384M
$15.3K 0.11%
441
CPRX
98
DELISTED
Catalyst Pharmaceutical
CPRX
$12K 0.09%
1,028
BEAM icon
99
Beam Therapeutics
BEAM
$2.71B
$11.2K 0.08%
467
SD icon
100
SandRidge Energy
SD
$501M
$2.49K 0.02%
159

Similar funds

Virtus Fund Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Virtus Fund Advisers held 119 positions worth $14.1M, down 0.28% from $14.2M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Virtus Fund Advisers's Q3 2023 filing shows 18 new, 17 increased, 9 reduced and 19 closed positions. Its largest new stake was Janus International: 7,720 shares worth $82.6K. The largest sale was HDFC Bank, an estimated $217K.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Materials and Consumer Discretionary.

  • Virtus Fund Advisers's largest Q3 2023 buy was Janus International: 7,720 shares worth $82.6K.
  • Virtus Fund Advisers added most to Vipshop in Q3 2023, an estimated $444K increase.
  • Virtus Fund Advisers's biggest Q3 2023 reduction was HDFC Bank, cutting an estimated $217K.
  • Virtus Fund Advisers fully exited Consolidated Water Co in Q3 2023, selling an estimated $132K.
  • Virtus Fund Advisers's ten largest holdings make up 69% of its $14.1M portfolio in Q3 2023.
  • Virtus Fund Advisers opened 18 new positions and closed 19 in Q3 2023.
  • Virtus Fund Advisers's portfolio value fell 0.28% quarter-over-quarter to $14.1M.

Based on Virtus Fund Advisers's 13F filing for Q3 2023, filed 8 Nov 2023.